NMRA vs PH
Neumora Therapeutics, Inc. (NMRA) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
NMRA currently screens at market cap $283.5M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the NMRA and PH stock pages for the full models.
Not investment advice.